| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHPSYC.1977.01770140126014 |
| P953 | full work available at URL | http://jamanetwork.com/journals/jamapsychiatry/fullarticle/491674 |
| P698 | PubMed publication ID | 14603 |
| P2093 | author name string | S. H. Snyder | |
| H. I. Yamamura | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 236-239 | |
| P577 | publication date | 1977-02-01 | |
| P1433 | published in | JAMA Psychiatry | Q635830 |
| Archives of General Psychiatry | Q105737481 | ||
| P1476 | title | Antidepressants and the Muscarinic Acetylcholine Receptor | |
| P478 | volume | 34 |
| Q71050479 | 3H-Imipramine binding sites in the rat brain. Selective localization on serotoninergic neurones |
| Q41551368 | A Pilot Study of the Mechanism of Action of Desipramine |
| Q34511940 | A double-blind placebo-controlled study to compare the autonomic effects of fluvoxamine with those of amitriptyline and doxepin in healthy volunteers |
| Q67777705 | A nicotinic receptor antagonist enhances the hypothermic response to a muscarinic agonist |
| Q68205188 | Acetylcholine and affective disorder |
| Q40504522 | Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline |
| Q72506801 | Acute extrapyramidal side effects: Serum levels of neuroleptics and anticholinergics |
| Q41131303 | Adrenergic influences on the control of blood-brain barrier permeability. |
| Q40305443 | Adverse effects of antidepressant drugs. Part 2: 'Second generation' antidepressants and rational decision making in antidepressant therapy |
| Q35364211 | Adverse effects of antidepressants in the elderly |
| Q53864705 | Affinity of nortriptyline and its E-10-hydroxy metabolite for muscarinic receptors. |
| Q24615575 | Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity |
| Q72426458 | Amitriptyline: Long-term treatment elevates α-adrenergic and muscarinic receptor binding in mouse brain |
| Q52213214 | Amoxapine and amitriptyline. II. Specificity of cognitive effects during brief treatment of depression. |
| Q70770682 | An enhanced sensitivity of muscarinic cholinergic receptor associated with dopaminergic receptor subsensitivity after chronic antidepressant treatment |
| Q24672336 | Antagonism by antidepressants of muscarinic acetylcholine receptors of human brain |
| Q45227694 | Anticholinergic serum levels and cognitive performance |
| Q60050316 | Antidepressant drugs and ethanol: Behavioral and pharmacokinetic interactions in mice |
| Q70572446 | Antidepressant selection in the elderly |
| Q48945939 | Antidepressant withdrawal syndromes: phenomenology and pathophysiology |
| Q41041144 | Antidepressants and heart-rate variability in older adults: a population-based study |
| Q48728797 | Antidepressants and opiates interactions: pharmacological and biochemical evidences |
| Q35674766 | Antidepressants in the general hospital |
| Q40622075 | Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms |
| Q34560423 | Antipsychotic withdrawal symptoms: phenomenology and pathophysiology |
| Q39577906 | Assessment and treatment of affective illness in the elderly |
| Q41839266 | Binding affinities of four tricyclic antidepressive drugs to muscarinic cholinergic receptors in human parotid gland |
| Q43203936 | Bradykinin receptors in intestinal smooth muscles and their post-receptor events related to calcium |
| Q44587875 | Brain histamine receptors as targets for antidepressant drugs |
| Q53201469 | Can an adjuvant treatment or a pharmacologic prevention be common to several diseases? The case of those associated to neuromediator defects |
| Q43610821 | Cardiac muscarinic cholinergic receptors. Biochemical identification and characterization |
| Q40113701 | Central nervous system receptors in neuropsychiatric disorders |
| Q49111955 | Cerebral Histamine: Indications for Neuronal and Vascular Regulation |
| Q34409219 | Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders. |
| Q70804779 | Characteristics and regulation of high affinity [3H]imipramine binding to rat hippocampal membranes |
| Q38967981 | Cholinergic involvement in mental disorders |
| Q33921518 | Cholinergic neurotransmission seems not to be involved in depression but possibly in personality |
| Q40137447 | Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning |
| Q48640640 | Chronic imipramine treatment-induced changes in acetylcholinesterase (EC 3.1.1.7) activity in discrete rat brain regions |
| Q72531337 | Clinical Psychiatry and Cardiovascular Disease in the Aged |
| Q71758586 | Clinical investigations into antidepressive mechanisms. I. Antihistaminic and cholinolytic effects: amitriptyline versus promethazine |
| Q69970878 | Clinical studies of the effect of (+) and (-)-oxaprotiline upon noradrenaline uptake |
| Q48661945 | Comparison of central gastric antisecretory effects of desmethylimipramine, doxepin and pirenzepine in rats |
| Q34622332 | Comparison of the effects of binodaline and amitriptyline on peripheral autonomic functions in healthy volunteers |
| Q34622686 | Comparison of the effects of chronic administration of ciclazindol and desipramine on pupillary responses to tyramine, methoxamine and pilocarpine in healthy volunteers |
| Q41987112 | Comparison of the effects of desipramine on noradrenaline- and methoxamine-evoked venoconstriction in man. |
| Q41781797 | Correlations between Serum Ami- and Nortriptyline Concentrations and Psychomotor Performance |
| Q40085183 | Current concepts on the mechanisms of action of antidepressant drugs |
| Q72427071 | Demonstration of specific “high affinity” binding sites for [3H] imipramine on human platelets |
| Q49157270 | Differential binding of 3H-imipramine and 3H-mianserin in rat cerebral cortex |
| Q52066687 | Distinct memory impairments following electroconvulsive therapy and imipramine. |
| Q70878250 | Distribution of Specific High‐Affinity Binding Sites for [3H]Imipramine in Human Brain |
| Q70883101 | Does high affinity [3H] imipramine binding label serotonin reuptake sites in brain and platelet? |
| Q38353242 | Drug safety and tolerability in prophylactic migraine treatment. |
| Q33718836 | Drug-induced cognitive impairment in the elderly |
| Q34009583 | Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management |
| Q69330525 | Dysbalance of neuronal second messenger function in the aetiology of affective disorders: a pathophysiological concept hypothesising defects beyond first messenger receptors |
| Q28194862 | Effect of amitriptyline on gastric ulceration |
| Q71050718 | Effect of antidepressant drugs on carbachol chloride-induced wet dog shake behaviour in rats |
| Q71248388 | Effect of antidepressant drugs on serotonergic and adrenergic receptors |
| Q51170618 | Effect of imipramine treatment on changes in heart rate and blood pressure during postural and isometric handgrip tests. |
| Q48153293 | Effect of nomifensine and other antidepressant drugs on acetylcholine turnover in various regions of rat brain |
| Q48512449 | Effect of tianeptine on the central cholinergic system: involvement of serotonin |
| Q34175745 | Effects of Antiparkinsonian Drugs on Muscarinic Receptor Binding in Rat Brain, Heart and Lung |
| Q72388743 | Effects of Desipramine Treatment upon Central Adrenoceptor Function in Normal Subjects |
| Q67272904 | Effects of acute and chronic desmethylimipramine on levels of cyclic AMP in vivo |
| Q37498394 | Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial |
| Q72890725 | Effects of antidepressant drugs on different receptors in the brain |
| Q51273301 | Effects of antidepressants and anticholinergics in a mouse “behavioral despair” test |
| Q44846262 | Effects of clonidine and tricyclic antidepressants on gastric smooth muscle contractility |
| Q43140189 | Effects of methylprednisolone on exercise-induced increases of plasma levels of polymorphonuclear elastase and myeloperoxidase in man. Preliminary results |
| Q72531398 | Effects of some rigid analogues of imipramine and amitriptyline on the uptake of noradrenaline, serotonin and choline in rat brain synaptosomes |
| Q70981219 | Effects of tricyclic antidepressants on muscarinic cholinergic receptor binding in mouse brain |
| Q39926908 | Evidence for the pharmacological similarity between the central presynaptic muscarinic autoreceptor and postsynaptic muscarinic receptors |
| Q37423106 | Fluvoxamine: an antidepressant for the elderly? |
| Q49109788 | From animal experiments to clinical trials: Aspects of the transposition in psychopharmacology |
| Q34562556 | High affinity binding of 3H-paroxetine and 3H-imipramine to rat neuronal membranes |
| Q72431754 | High affinity binding of tricyclic antidepressants to histamine H1-receptors: Fact and artifact |
| Q41491757 | High-affinity 3H-imipramine binding in rat cerebral cortex |
| Q66921698 | Identification of direct competition for, and indirect influences on, striatal muscarinic cholinergic receptors: in vivo [3H]Quinuclidinyl benzilate binding in rats |
| Q48784337 | In vitro studies on the effect of beta-carbolines on the activities of acetylcholinesterase and choline acetyltransferase and on the muscarinic receptor binding of the rat brain. |
| Q51867649 | Individual differences in effects of tricyclic antidepressants and anticholinergic drugs on operant behavior in the squirrel monkey |
| Q35939213 | Influence of Amineptine on Changes of Blood Pressure Evoked by Norepinephrine and Dopamine |
| Q40715085 | Inhibition of SK3 channels in the TE671 human medulloblastoma cell line by desipramine and imipramine |
| Q43991996 | Inhibition of acetylcholinesterase from Electrophorus electricus (L.) by tricyclic antidepressants. |
| Q72905196 | Interaction of impramine with the ionic channel of the acetylcholine receptor of motor endplate and electric organ |
| Q48233456 | Interaction of psychotropic drugs with brain muscarinic cholinoceptors: similarities of biperiden with pirenzepine in receptor binding properties |
| Q53781942 | Interactions of tricyclic antidepressants with a synaptic ion channel |
| Q71051345 | Intraocular pressure in patients receiving psychotropic medications |
| Q44782601 | Lack of effect of ephedrine on opiate analgesia |
| Q40897368 | Learning and memory in monozygotic twins discordant for schizophrenia. |
| Q41445384 | Localization of [3H]-imipramine binding sites in rat brain by light microscopic autoradiography |
| Q72863771 | Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding |
| Q42857894 | Long-term atropine treatment lowers the efficacy of carbachol to stimulate phosphatidylinositol breakdown in the cerebral cortex and hippocampus of rats |
| Q73547431 | Long-term clomipramine treatment upregulates forebrain acetylcholine muscarinic receptors, and reduces behavioural sensitivity to scopolamine in mice |
| Q43698600 | Long-term treatment with antidepressant drugs reduces the sensitivity of cortical cholinergic neurons to the activating actions of stress and the anxiogenic drug FG 7142. |
| Q44489489 | Mapping muscarinic receptors in human and baboon brain using [N-11C-methyl]-benztropine. |
| Q33949205 | Medication safety in residential aged-care facilities: a perspective |
| Q48619904 | Memory effects of clomipramine treatment: Relationship to CSF monoamine metabolites and drug concentrations in plasma |
| Q33630488 | Metabolism of tricyclic antidepressants |
| Q48967980 | Modulation of rat brainα2- and β-adrenergic receptor sensitivity following long-term treatment with antidepressants |
| Q37808126 | Mood Drugs |
| Q70883147 | Muscarinic cholinergic binding sites on intact human lymphocytes |
| Q35228641 | Neural symptoms induced by tricyclic antidepressants: phenomenology and pathophysiology |
| Q38369124 | Neurobiology of brain-gut interactions. Implications for ulcer disease |
| Q48388239 | Neuropharmacological modification of central catecholamines: effects on pinealectomy-induced convulsions |
| Q40111587 | Neurotransmitter Hypotheses of Depression: Research Update |
| Q70460000 | Nitroimipramines - synthesis and pharmacological effects of potent long-acting inhibitors of [3H] serotonin uptake and [3H] imipramine binding |
| Q48249072 | Noradrenergic denervation prevents sensitization of rat forebrain neurons to serotonin by tricyclic antidepressant treatment |
| Q44656415 | PET quantification of muscarinic cholinergic receptors with [N-11C-methyl]-benztropine and application to studies of propofol-induced unconsciousness in healthy human volunteers |
| Q68697220 | Paraganglionic cell response to chronic imipramine and handling stress: an ultrastructural study |
| Q41333430 | Pargyline reduces/prevents neuroleptic-induced acute dystonia in monkeys |
| Q41337684 | Personality factors predisposing to depression correlate significantly negatively with M1-muscarinic and beta-adrenergic receptor densities on blood cells |
| Q40078001 | Pharmacologic Mechanisms of Action of Antidepressants |
| Q40087979 | Pharmacosexology: the effects of drugs on sexual function a review |
| Q44683069 | Potentiation of imipramine-induced antinociception by nicotine in the formalin test |
| Q42111038 | Principles of antidepressant use. |
| Q39470233 | Psychiatric drugs and inhibited female orgasm |
| Q36272836 | Psychoactive drugs and human sexual behavior: the role of serotonergic activity |
| Q34109378 | Psychopharmacology in medical practice--the benefits and the risks |
| Q72523432 | Rational Use of Psychoactive Drugs in the Geriatric Patient |
| Q34245764 | Receptor Binding Profile of Quinupramine, a New Tricyclic Antidepressant |
| Q47591134 | Relationship between extrapyramidal symptoms and serum anticholinergic levels in treated chronic schizophrenics |
| Q48165398 | Repeated electroconvulsive shock does not change [3H]-paroxetine binding to the 5-HT uptake site in rat cortical membranes |
| Q72465801 | Sedative/anxiolytic effects of antidepressants in animals |
| Q60050303 | Serotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouse |
| Q42267364 | Sexual dysfunction and clomipramine |
| Q42177042 | Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the antidepressant activity of amitriptyline but not desipramine, in the forced swim test in mice |
| Q42156660 | Specific [3H]-imipramine binding in rat brain [proceedings] |
| Q41752061 | Specific tricyclic antidepressant binding sites in rat brain |
| Q39240480 | The "neuroleptic" antipsychotic drugs. 2. Neurologic side effects |
| Q38926516 | The Role of Metabolites of Antidepressants in the Treatment of Depression |
| Q24672644 | The binding of some antidepressant drugs to brain muscarinic acetylcholine receptors |
| Q42631406 | The cellular mechanism of action of nimodipine (BAY e 9736), a new calcium antagonist [proceedings] |
| Q70237305 | The cholinolytic biperiden in depression. An acute placebo controlled study |
| Q70477135 | The effect of aging on the positive chronotropic response to amitriptyline |
| Q72857040 | The effect of psychoactive drugs on beta-adrenergic receptor binding sites in rat brain |
| Q41897251 | The effects of BTS 54,505, a metabolite of sibutramine, on monoamine and excitatory amino acid-evoked responses in the rat dorsolateral geniculate nucleus in vivo |
| Q42225750 | The effects of alaproclate on the pupillary responses to tyramine, phenylephrine and pilocarpine in depressed patients |
| Q36097030 | The interaction of trazodone with rat brain muscarinic cholinoceptors |
| Q40844880 | The problems of anticholinergic adverse effects in older patients |
| Q44452773 | The short-term clinical efficacy of amitriptyline in the management of idiopathic feline lower urinary tract disease: a controlled clinical study |
| Q39371998 | The use of medicines with anticholinergic effects in older people: a population study in an urban area of Sweden |
| Q51261356 | Therapeutic usefulness of amitriptyline in spastic colon syndrome. |
| Q39725957 | Treatment-resistant depression in the elderly |
| Q34122901 | Tricyclic antidepressant drugs block histamine H2 receptor in brain |
| Q71572165 | Tricyclic antidepressants and peripheral anticholinergic activity |
| Q73981247 | Tricyclic antidepressants block cholinergic nicotinic receptors and ATP secretion in bovine chromaffin cells |
| Q39197698 | Tricyclic antidepressants block histamine H1 receptors of mouse neuroblastoma cells |
| Q39287214 | Tricyclic antidepressants: Potent blockade of histamine H1 receptors of guinea pig ileum |
| Q68546921 | Use of tricyclic antidepressants in patients with glaucoma. Assessment and appropriate precautions |
Search more.